TNF and rheumatoid arthritis: Drugs which inhibit TNF (tumour necrosis factor inhibitors (TNFi)) were the first available biologic therapies [2], but the choice has expanded, and since 2010, tocilizumab (TCZ), a humanised monoclonal antibody against the IL-6 receptor, has been available for use in RA.